CBD Health Shop NEWRY

17/04/2026

In Part 1 of a 2-part episode, we speak with Robin Swan of Swan Apothecary. Robin has spent many years working with cannabis medicine and helping patients understand how to use it safely and effectively. In this first part of our conversation we’re going to talk about how cannabis

17/04/2026

14/04/2026

Parkinson’s can affect movement, sleep, mood, and overall quality of life. Many patients are exploring complementary options alongside their care plan—and emerging research and patient reports are shedding light on how cannabis may offer supportive relief for certain symptoms.

Reports from patients using cannabis noted:
• Reduced tremor and rigidity
• Relief from muscle spasms and discomfort
• Improved mood and sleep quality
• Easier mobility and fewer “freezing” episodes

Research suggests that THC interacts with CB1 and CB2 receptors in the body, supporting neurochemical balance and helping calm neuroinflammation. CBD is recognized for its neuroprotective properties and its role in reducing oxidative stress, which may be supportive in slowing progression. Some studies also note that CBD may influence dopamine activity, which plays a key role in Parkinson’s symptoms.

Clinical observations have shown that inhalation methods may provide more immediate symptom relief for tremor, pain, and muscle spasm in many individuals.

Every person’s journey with Parkinson’s is unique. Education and informed conversations with healthcare providers are essential when considering supportive options.

Learn more in the comments below.

14/04/2026

Shocking Win: IVERMECTIN and MEBENDAZOLE Testimonial 36 year old mother with Stage 3C Colon Cancer, 10cm tumor and then recurrence in multiple lymph nodes, achieves negative PET scan after 3 months

Another "CANCER FREE" Success Story!

This one is incredible...

STORY:
Feb.2023: 36 year old mom diagnosed with Stage 3C Colon Cancer, 10cm tumor had surgery and 6 months of chemo.
Sep.2023: Cancer free (the traditional way)
Apr.2024: CEA 3.8 at lowest level
July.2024: CEA starts rising to 6.8
Sep.2024: Recurrence of Cancer in multiple lymph nodes up to 3cm confirmed
Oct.14, 2024: CEA peaks at 10.3, started low dose Ivermectin & Mebendazole
Oct.21, 2024: Started chemo again, increased repurposed drugs:
Ivermectin 1mg/kg/day
Mebendazole 1500mg/day
Nov.18, 2024: CEA drops to 3.4
Dec.13, 2024: CT shows shrinking lymph nodes:
1.5cm to 1.3cm,
1.4cm to 1.2cm,
but largest 3.0cm lymph node remained the same.
Continued Ivermectin & Mebendazole and Melatonin
Mid Jan.2025: PET scan was negative!!
MY TAKE…

3 months, that’s all it took!!
Colon Cancer recurrence, treated with chemo, Ivermectin and Mebendazole - a powerful combination leading to a negative PET Scan.
That means the cancer cells are dead, confirmed by the normal CEA.
These stories are truly remarkable!!

Imagine what the Oncologists are missing by IGNORING Ivermectin, Mebendazole and Fenbendazole!
We must fix Oncology!
Many more testimonials coming! Every day
I was working on a Fenbendazole paper today but I can't tell you about it...yet

source: Oncology research guidelines and clinical study data

disclaimer: This information is for educational purposes only and not a substitute for professional medical advice or treatment

09/04/2026

Autoimmune disease is the body staying stuck in a bad inflammatory conversation, where immune signals keep firing when they should be standing down. In “Cannabinoids and autoimmune diseases: A systematic review” (2016), Katchan and colleagues reviewed how cannabinoids influence immune signaling across autoimmune conditions and found that these compounds can modulate neurotransmitter and cytokine release, suppress leukocyte proliferation, induce apoptosis in T cells and macrophages, and reduce pro inflammatory cytokine output.

The review also notes preclinical benefits in models of arthritis, multiple sclerosis, and type 1 diabetes, while acknowledging that human evidence remains limited and inconclusive.

That’s what makes cannabinoids important in autoimmune inflammation. They are not just being discussed as pain relievers. They are being studied as immune modulators that may help calm part of the inflammatory machinery itself.

This review specifically describes cannabinoids as having immunosuppressive and anti-fibrotic promise in autoimmune disorders, which matters because autoimmune damage is often driven by cells remaining activated too long, releasing excess inflammatory signals, and perpetuating tissue injury over time.

The honest part is just as important - this is not proof that every cannabinoid helps every autoimmune disease, and it is not a license to overstate the science. The review makes clear that most of the stronger evidence was preclinical, while human trials were still scarce.

But the reason this lane keeps growing is simple. Cannabinoids appear capable of dialing down parts of the immune overreaction that drive autoimmune inflammation, and that puts them in a serious conversation about restoring balance where the body has lost it.

-Mike Robinson, The Researcher OG
Study Link: https://doi.org/10.1016/j.autrev.2016.02.008

08/04/2026

Doctors told Slavka Geary of the UK she might have only a year to live after being diagnosed with HER2+ breast cancer. Instead of relying on just one approach, she combined conventional treatment with lifestyle changes, natural therapies, supplements, and cannabis oil. Today she is in remis

17/03/2026

Jason Berger of Ohio was only 34 years old when he was diagnosed in 2004 with an extremely rare form of brain cancer: Central Nervous System Lymphoma, which is fast growing and deadly. Over the last two decades he has undergone recurrences 5 times, had surgery and undergone a stem

07/03/2026